Alaunos therapeutics inc TCRT.US Overview Analysis

US StockHealth Care
(No presentation for TCRT)

TCRT AI Analysis Overview

Keys for Bullish View

  • Value≥4
  • Dividend≥2

Analysis Conclusion

The stock has a lower value rating; if aiming for value investing, existing long-term positions might require gradual reduction.

TCRT Current Performance

4.88%

Alaunos therapeutics inc

1.31%

Avg of Sector

0.58%

S&P500

Top 10 High Relevance to TCRT

  • ALMS Alumis inc
    Value -Trend 2Swing Trading 4Whale Interest 3Dividend 1
    See more

TCRT Profile

Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.

Price of TCRT